Drug profile

The FDA adverse-event record for Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6), Mlv; Infectious Bovine Rhin

32 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6), Mlv; Infectious Bovine Rhin. See the species affected, top reactions, and outcomes below.

32
adverse-event reports
90.6%
death-coded share
Cattle
most-reported species
28
Lack of efficacy (bacteria) - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
32
Total Reports
29
Deaths Reported
90.6%
Death Rate

Active Ingredients

Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6), Mlv; Infectious Bovine Rhin

Administration Routes

UnknownNasal

Species Affected

Cattle 32

Most Affected Breeds

Cattle (other) 23
Mixed (Cattle) 6
Crossbred Bovine/Cattle 1
Maine-Anjou 1
Aberdeen Angus 1

Most Reported Reactions

Lack of efficacy (bacteria) - NOS 28
Death 20
Abnormal test result 10
CULTURE/TITER DATA ABNORMAL 9
Lack of efficacy - NOS 5
Increased mortality rate 4
Abnormal necropsy finding 4
NT - Abnormal necropsy finding NOS 3
Other abnormal test result NOS 3
Unrelated death 3
Joint swelling 2
PR-LUNG(S), LESION(S) 1

Outcome Breakdown

Died
29 (49.2%)
Outcome Unknown
23 (39.0%)
Ongoing
4 (6.8%)
Recovered/Normal
2 (3.4%)
Euthanized
1 (1.7%)

Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6), Mlv; Infectious Bovine Rhin Adverse Event Insights

32 reports name Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6), Mlv; Infectious Bovine Rhin; 29 recorded a death outcome (90.6% of reported events, not a population-level mortality rate). Active ingredient: Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6), Mlv; Infectious Bovine Rhin. Administration routes: Unknown, Nasal.

By species: Cattle (32 reports). By breed: Cattle (other) (23), Mixed (Cattle) (6), Crossbred Bovine/Cattle (1).

Leading clinical signs: Lack of efficacy (bacteria) - NOS (28), Death (20), Abnormal test result (10), CULTURE/TITER DATA ABNORMAL (9). Outcome, 59 coded reports: Died leads at 49.2%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.